MyFinsight
Home
About
Contact
dfph: the income statement
Download
Download image
Net loss
-$16,504K
(-2.43%↓ Y/Y)
Loss before
provision for income taxes
-$16,504K
(-2.43%↓ Y/Y)
Clinical Research Trials
And Other Revenue
$474K
Dispensary Revenue
$75,895K
Health Care Patient
Service
$60,195K
Total other
non-operating loss
-$8,450K
(-273.89%↓ Y/Y)
Loss from operations
-$8,054K
(41.86%↑ Y/Y)
Total operating
revenue
$136,564K
(36.70%↑ Y/Y)
Other, net
-$403K
(-632.73%↓ Y/Y)
Change in fair value of
conversion option...
-$5,977K
Change in fair value of
derivative warrant...
$150K
(850.00%↑ Y/Y)
Interest expense, net
$1,920K
(-13.71%↓ Y/Y)
Total operating
expenses
$144,618K
(27.13%↑ Y/Y)
Depreciation and
amortization
$1,723K
(9.54%↑ Y/Y)
Selling, general and
administrative expense
$25,251K
(-5.24%↓ Y/Y)
Direct
costs-Dispensary Revenue
$63,072K
Direct costs-Health
Care Patient Service
$54,572K
Back
Back
Income Statement
source: myfinsight.com
Oncology Institute, Inc. (DFPH)
Oncology Institute, Inc. (DFPH)